Drug FDA Class II Ongoing Mislabeling
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
SpecGx, LLC Published Jan 14, 2026
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 60/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact SpecGx, LLC or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Hazards
Missing Tablet Imprint · primary
Affected products (1)
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
OXYCODONE AND ACETAMINOPHEN · 74,544 bottles
NDC: 0406-0512, 0406-0522, 0406-0523, 0406-0512-01, 0406-0512-05, 0406-0512-62, 0406-0512-23, 0406-0512-91, 0406-0522-01, 0406-0522-62, 0406-0522-05, 0406-0522-23, 0406-0523-01, 0406-0523-62, 0406-0523-05, 0406-0523-23, 0406052201
Lot codes: 0522J23493
Code info: Lot: 0522J23493, expires: 03/2027.
Affected areas
Nationwide
Timeline
- InitiatedDec 16, 2025
- PublishedJan 14, 2026
- Recall number
- D-0255-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.